1,2-Distearin - CAS 51063-97-9
Catalog: |
BB027312 |
Product Name: |
1,2-Distearin |
CAS: |
51063-97-9 |
Synonyms: |
Distearin; 1,2-Distearoyl-rac-glycerol; Glycerol 1,2-distearate; D-alpha,beta-Distearin; rac-1,2-Distearoylglycerol; 18:0 DG; DG(18:0/18:0/0:0)[rac] |
IUPAC Name: | (3-hydroxy-2-octadecanoyloxypropyl) octadecanoate |
Description: | 1,2-Distearin (CAS# 51063-97-9) is used in the preparation of lipophilic peptides for gene delivery. It is also a derivative of Glyceryl Distearate (G601525) which is used in the preparation of liposomes for drug delivery of topically delivered drugs. |
Molecular Weight: | 625.02 |
Molecular Formula: | C39H76O5 |
Canonical SMILES: | CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCC |
InChI: | InChI=1S/C39H76O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(41)43-36-37(35-40)44-39(42)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h37,40H,3-36H2,1-2H3 |
InChI Key: | UHUSDOQQWJGJQS-UHFFFAOYSA-N |
Boiling Point: | 662.29 °C at 760 mmHg |
Melting Point: | 72.2-73.9 °C |
Purity: | > 99 % |
Density: | 0.92 g/cm3 |
Solubility: | Soluble in hot alcohol, benzene, ether, and acetone |
Appearance: | Powder |
Shelf Life: | 1 Year |
Storage: | Store at -20 °C |
LogP: | 11.95670 |
Publication Number | Title | Priority Date |
CN-113461041-A | Method for removing oxalate from sodium aluminate solution | 20210803 |
CN-113372129-A | Hydrophobic light ceramsite prepared from restored soil and preparation method thereof | 20210720 |
CN-113512196-A | Alcohol solution of alkyl silanol and preparation method | 20210719 |
CN-113429420-A | Preparation method of high-sensitivity temperature-sensing reversible color-changing microcapsule | 20210609 |
AU-2021102985-A4 | Pharmaceutical composition for treating atherosclerosis | 20210531 |
PMID | Publication Date | Title | Journal |
22465412 | 20120615 | Taste masked lipid pellets with enhanced release of hydrophobic active ingredient | International journal of pharmaceutics |
22050402 | 20111201 | Nano-scaled pH-responsive polymeric vesicles for intracellular release of doxorubicin | Journal of drug targeting |
18805483 | 20090101 | Immediate release pellets with lipid binders obtained by solvent-free cold extrusion | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V |
17551809 | 20080101 | Sheddable coatings for long-circulating nanoparticles | Pharmaceutical research |
16796375 | 20060414 | Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice | The AAPS journal |
Complexity: | 593 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 624.56927552 |
Formal Charge: | 0 |
Heavy Atom Count: | 44 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 624.56927552 |
Rotatable Bond Count: | 38 |
Topological Polar Surface Area: | 72.8 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 16.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[91-04-3]
2,6-Bis(hydroxymethyl)-p-cresol
-
[6342-17-2]
1,4-Bis(acryloyl)piperazine
-
[500-49-2]
5-Propylbenzene-1,3-diol
-
[784-04-3]
9-Acetylanthracene
-
[6313-33-3]
Formamidine hydrochloride
INDUSTRY LEADERS TRUST OUR PRODUCTS